Trial record 3 of 519 for:    Open Studies | "Substance-Related Disorders"

Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2006 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00302575
First received: March 13, 2006
Last updated: February 1, 2010
Last verified: August 2006
  Purpose

The main purpose of this study is to examine whether improved integration between the community supervision system and outpatient addiction treatment system can improve treatment adherence, drug use and public safety outcomes among drug-involved inmates re-entering the community.


Condition Intervention
Substance-Related Disorders
Behavioral: Collaborative Behavioral Management
Procedure: Integrated parole and outpatient addiction treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Rearrest

Secondary Outcome Measures:
  • Drug use

Estimated Enrollment: 420
Study Start Date: February 2005
Estimated Study Completion Date: August 2007
Detailed Description:

The target population consists of male and female parolees with a history of substance abuse treatment who are at moderate-to-high-risk of recidivism. They will recruited from in the criminal justice system and/or transitional residential drug treatment within one or two months of release or at the time they first report for parole supervision.

Participants from six states (KY, OR, RI, CT, VA, DE) will be randomized into the Step'n Out condition (integration of community supervision and addiction treatment with behavioral management) or a comparison condition including traditional community supervision and addiction treatment. Research interviews at baseline, and 3 and 9 months after release from confinement will assess study participants' outcomes.

The Step'n Out intervention will produce significantly better outcomes than the standard referral condition with respect to: recidivism rates (revocation, rearrest on a new charge, reconviction, reincarceration), as assessed 3 and 9 months after the end of the intervention; treatment participation (i.e., proportion of planned sessions attended, proportion of planned days retained in treatment, type of discharge [successful completion, transfer to another program, elopement, administrative discharge, return to custody], as assessed after the end of the intervention; self-reported drug use, criminal activity, and psychosocial functioning, as assessed 3 and 12 months after the end of the intervention; cost-effectiveness; collaboration between the supervision officer and treatment counselor ; and therapeutic alliance with the clients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. be at least 18 years old and speak English;
  2. have probable drug dependence immediately prior to incarceration as determined by a score of 3 or higher on the TCU Drug Screen II;
  3. be at moderate-to-high-risk of drug relapse and/or recidivism as determined by a Lifestyle Criminality Screening Form (LCSF) score of 7 or greater, or a history of 2 or greater prior treatments for drug-related problems or drug-related convictions;
  4. must have substance use treatment as a mandated or recommended condition of parole.

Exclusion Criteria:

  1. psychotic features;
  2. parole or probation conditions that prohibit them from participating in the protocol.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00302575

Contacts
Contact: Peter D Friedmann, MD, MPH 401-444-3347 pfriedmann@lifespan.org
Contact: Kristina Richards, MA 401-444-5838 krichards@lifespan.org

Locations
United States, California
University of California, Los Angeles Recruiting
Los Angeles, California, United States, 90025
Contact: William Burdon, PhD    310-445-0874 ext 333    wburdon@ucla.edu   
Contact: Carter Bartee, BA    503-241-7145    cbartee@ucla.edu   
Principal Investigator: Michael Prendergast, PhD         
United States, Connecticut
Connecticut Deptartment of Mental Health & Addiction Services Recruiting
Hartford, Connecticut, United States, 06134
Contact: Eleni Rodis    860-418-6663    Eleni.Rodis@po.state.ct.us   
Principal Investigator: Linda K Frisman, PhD         
United States, Delaware
University of Delaware Recruiting
Newark, Delaware, United States, 19716
Contact: Daniel J O'Connell, PhD    302-831-4649    oconnell@UDel.Edu   
Principal Investigator: Steven S. Martin, PhD         
United States, Kentucky
University of Kentucky Not yet recruiting
Lexington, Kentucky, United States, 40536
Contact: Conrad J Wong, PhD    859-323-6774    conrad.wong@uky.edu   
Principal Investigator: Carl G Leukefeld, DSW         
United States, Virginia
Virginia Commonwealth University Not yet recruiting
Richmond, Virginia, United States, 23284
Contact: Anne G Rhodes, MA    804-827-1160    agrhodes@vcu.ed   
Contact: Melinda Gales    (804) 628-0646    mgales@mail1.vcu.edu   
Principal Investigator: Faye S Taxman, PhD         
Sponsors and Collaborators
Substance Abuse and Mental Health Services Administration (SAMHSA)
Investigators
Principal Investigator: Peter D Friedmann, MD, MPH Rhode Island Hospital
  More Information

Additional Information:
No publications provided by National Institute on Drug Abuse (NIDA)

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00302575     History of Changes
Other Study ID Numbers: 1U01DA016191
Study First Received: March 13, 2006
Last Updated: February 1, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute on Drug Abuse (NIDA):
Substance-Related Disorders
Prisoners

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 22, 2014